Discontinued — last reported Q3 '23

Investing

Acquisitions

Over 4 years (FY 2021 to FY 2025), Acquisitions shows an upward trend with a 37.4% CAGR.

Analysis

StatementCash Flow Statement
SectionInvesting
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2017
Last reportedQ3 2023

How to read this metric

High spending indicates an aggressive growth or diversification strategy, while low spending suggests a focus on organic growth or internal consolidation.

Detailed definition

This metric tracks the cash paid to acquire other businesses or business units, net of any cash acquired in the transact...

Peer comparison

Varies significantly based on M&A cycles; peers in the healthcare sector frequently use acquisitions to gain access to new diagnostic or therapeutic technologies.

Metric ID: acquisitions

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$9.77M$0.00$35.92M$0.00$6.87M$19.10M$992.13M$0.00$1.52M$103.18M$7.51M$3.08M$19.70M$0.00$670.00K$0.00$138.58M$522.00K$0.00$24.88M
QoQ Change-100.0%-100.0%+178.1%>999%-100.0%>999%-92.7%-59.0%+539.7%-100.0%-100.0%-99.6%-100.0%
YoY Change-29.7%>999%-77.8%+440.2%-99.2%>999%-100.0%-91.1%-100.0%+603.5%-100.0%
Range$0.00$992.13M
CAGR+21.8%
Avg YoY Growth+391.0%
Median YoY Growth-77.8%

Frequently Asked Questions

What is ResMed's acquisitions?
ResMed (RMD) reported acquisitions of $24.88M in Q1 2026.
What is the long-term trend for ResMed's acquisitions?
Over 4 years (2021 to 2025), ResMed's acquisitions has grown at a 37.4% compound annual growth rate (CAGR), from $39.07M to $139.25M.
What does acquisitions mean?
Cash spent to buy other companies or business units.